BFM
FATE icon

Boothbay Fund Management’s Fate Therapeutics FATE Stock Holding History

Boothbay Fund Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,666
Closed -$17.6K – 1550
2024
Q4 		$17.6K Buy
+10,666
New +$26.9K ﹤0.01% 1424
2021
Q4 		– Hold
0
– – – 1984
2021
Q3 		– Hold
0
– – – 2005
2021
Q2 		– Hold
0
– – – 1959
2021
Q1 		– Hold
0
– – – 1656
2020
Q4 		– Hold
0
– – – 1312
2020
Q3 		– Hold
0
– – – 1121
2019
Q2 		– Sell
-36,800
Closed -$647K – 797
2019
Q1 		$647K Buy
+36,800
New +$581K 0.09% 316
2018
Q2 		– Hold
0
– – – 808
2018
Q1 		– Hold
0
– – – 757

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return